WAKIX has been studied in 3 clinical trials in adults with narcolepsy and 1 clinical trial in children 6-17 years old with narcolepsy.
In the clinical trials in patients with narcolepsy, WAKIX significantly reduced excessive daytime sleepiness (EDS) and the number of cataplexy attacks compared with placebo (sugar pill).
